Inflammation, Oxidative Stress, and Renal Fibrosis

Chronic inflammation and oxidative stress are central to the progression of kidney diseases. Pro-inflammatory cytokines and reactive oxygen species contribute to cellular injury, glomerulosclerosis, and tubular interstitial fibrosis. Persistent inflammation leads to irreversible changes in kidney structure, ultimately reducing functional nephron mass. Renal fibrosis is the final common pathway in both acute and chronic kidney conditions. Therapeutic strategies target key molecular pathways such as transforming growth factor-beta (TGF-β), nuclear factor kappa B (NF-κB), and the renin-angiotensin system. Antioxidants, anti-inflammatory agents, and antifibrotic drugs are under investigation to halt or reverse this progression. A better understanding of these mechanisms opens the door to personalized medicine and more effective renal protection strategies.

Topics covered:

• Molecular mechanisms of renal inflammation

• Fibrosis and its impact on kidney function

• Antioxidants and anti-inflammatory therapies

    Related Conference of Inflammation, Oxidative Stress, and Renal Fibrosis

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Inflammation, Oxidative Stress, and Renal Fibrosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in